Montana Aerospace AG

BATS-CHIXE:AEROZ Stock Report

Market Cap: CHF 962.3m

Montana Aerospace Valuation

Is AEROZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AEROZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AEROZ (CHF15.44) is trading below our estimate of fair value (CHF48.81)

Significantly Below Fair Value: AEROZ is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for AEROZ?

Key metric: As AEROZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AEROZ. This is calculated by dividing AEROZ's market cap by their current revenue.
What is AEROZ's PS Ratio?
PS Ratio0.6x
Sales€1.61b
Market Cap€1.03b

Price to Sales Ratio vs Peers

How does AEROZ's PS Ratio compare to its peers?

The above table shows the PS ratio for AEROZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.7x
SNR Senior
0.6x5.7%UK£591.3m
CHG Chemring Group
2x8.3%UK£980.1m
CHRT Cohort
2x13.5%UK£413.1m
AVON Avon Technologies
2x5.9%UK£427.1m
AEROZ Montana Aerospace
0.6x5.7%CHF 962.3m

Price-To-Sales vs Peers: AEROZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (1.7x).


Price to Sales Ratio vs Industry

How does AEROZ's PS Ratio compare vs other companies in the European Aerospace & Defense Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
No. of Companies11PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AEROZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the European Aerospace & Defense industry average (1.5x).


Price to Sales Ratio vs Fair Ratio

What is AEROZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AEROZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ratio1x

Price-To-Sales vs Fair Ratio: AEROZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AEROZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 15.44
CHF 22.32
+44.6%
16.3%CHF 27.90CHF 17.94n/a5
Nov ’25CHF 15.04
CHF 23.35
+55.3%
20.3%CHF 31.78CHF 18.46n/a5
Oct ’25CHF 20.10
CHF 24.28
+20.8%
20.8%CHF 31.80CHF 18.19n/a5
Sep ’25CHF 19.12
CHF 24.37
+27.4%
20.8%CHF 32.01CHF 18.31n/a5
Aug ’25CHF 18.65
CHF 24.15
+29.5%
20.4%CHF 32.03CHF 17.79n/a5
Jul ’25CHF 19.08
CHF 23.66
+24.0%
20.7%CHF 31.54CHF 17.36n/a5
Jun ’25CHF 19.52
CHF 23.22
+19.0%
22.1%CHF 32.04CHF 17.83n/a5
May ’25CHF 17.68
CHF 21.92
+24.0%
23.5%CHF 32.05CHF 17.79n/a5
Apr ’25CHF 16.87
CHF 22.33
+32.4%
26.9%CHF 32.07CHF 15.22n/a5
Mar ’25CHF 15.41
CHF 22.33
+44.9%
26.9%CHF 32.07CHF 15.22n/a5
Feb ’25CHF 16.49
CHF 22.42
+35.9%
27.1%CHF 31.99CHF 15.18n/a5
Jan ’25CHF 17.62
CHF 22.59
+28.2%
28.8%CHF 33.02CHF 14.96n/a5
Dec ’24CHF 15.52
CHF 22.05
+42.1%
27.2%CHF 33.01CHF 15.32n/a5
Nov ’24CHF 11.66
CHF 21.85
+87.4%
27.5%CHF 31.64CHF 15.32CHF 15.044
Oct ’24CHF 11.34
CHF 22.25
+96.2%
28.0%CHF 32.34CHF 15.30CHF 20.104
Sep ’24CHF 13.54
CHF 24.76
+82.9%
19.2%CHF 31.88CHF 19.92CHF 19.124
Aug ’24CHF 13.60
CHF 24.97
+83.6%
18.7%CHF 31.74CHF 19.49CHF 18.654
Jul ’24CHF 14.48
CHF 24.97
+72.5%
18.7%CHF 31.74CHF 19.49CHF 19.084
Jun ’24CHF 14.04
CHF 26.16
+86.3%
19.3%CHF 31.97CHF 19.63CHF 19.523
May ’24CHF 16.30
CHF 26.40
+62.0%
18.7%CHF 31.93CHF 19.96CHF 17.683
Apr ’24CHF 14.84
CHF 26.48
+78.4%
18.8%CHF 32.12CHF 20.01CHF 16.873
Mar ’24CHF 17.48
CHF 26.38
+50.9%
18.7%CHF 31.97CHF 19.98CHF 15.413
Feb ’24CHF 16.90
CHF 26.25
+55.3%
23.8%CHF 32.51CHF 20.00CHF 16.492
Jan ’24CHF 14.44
CHF 28.77
+99.2%
24.4%CHF 35.22CHF 19.03CHF 17.623
Dec ’23CHF 13.42
CHF 28.77
+114.4%
24.4%CHF 35.22CHF 19.03CHF 15.523
Nov ’23CHF 11.52
CHF 30.45
+164.3%
26.7%CHF 37.09CHF 19.02CHF 11.663

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies